Topical tacrolimus is effective against eczema in Wiskott-Aldrich syndrome (WAS).
The Wiskott-Aldrich syndrome is a rare X-linked immunodeficiency characterized by microplatelet thrombocytopenia and eczema. Eczema may be severe and facilitate entry of microorganism into the host. We report for the first time that eczema in infants with WAS can be effectively treated with topical ttacrolimus.